BVS vs MS · rev $573.3M vs P/E 20, $344.27B cap
Bioventus Inc (BVS) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
MS does not have a complete income-statement cache yet.
BVS currently screens at market cap $495.1M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BVS and MS stock pages for the full models.
Not investment advice.